340binformed.org

Henry Waxman Reflects on 340B’s 30-Year Legacy

Print ArticleNov. 10, 2022— It is safe to say the 340B drug pricing program would not be what it is today without former Congressman Henry Waxman. In fact, 340B might not even exist. As chairman of the key congressional committee with jurisdiction over health care programs, the California Democrat was the lead author of the […]

30 Years of Care: A Happy, Healthy Anniversary for 340B!

Print ArticleNov. 4, 2022— Today marks the 30th anniversary of the enactment of the 340B drug pricing program. With his signature on Nov. 4, 1992, President George H.W. Bush completed a bipartisan effort in Congress to protect the health care safety net and boost care for people living with low incomes. The new program was […]

Research Continues to Illustrate 340B’s Valuable Role

October 20, 2022— A pair of new research reports adds to the growing body of evidence of the critical role 340B hospitals play in caring for patients living with low incomes. The research also demonstrates the crucial part these hospitals played in … [Read More...]

Pharmacy Technicians Keep 340B Running Smoothly Despite Workforce Challenges

Oct. 18, 2022– When patients consider their interactions with a hospital pharmacy department, they immediately might think of a pharmacist. However, all these departments also rely on pharmacy technicians to operate smoothly. These dedicated techs … [Read More...]

Faces of 340B: Patients Are Skipping Medications Because of Drug Company Restrictions

Sept. 23, 2022 – Southwest Mississippi Regional Medical Center (SMRMC) had big plans for how it could reach more patients in need in the communities that it serves. But that all changed when drug companies started restricting access to 340B drug … [Read More...]

Hospitals Say Medicare Must End 340B Cuts, Repay Harmed Facilities

September 19, 2022— Organizations representing hospitals participating in the 340B drug pricing program are calling on the Centers for Medicare & Medicaid Services (CMS) to put a permanent end to controversial payment cuts for outpatient drugs … [Read More...]

340B Makes Major Contributions to Cancer Care

Sept. 13, 2022– President Biden’s call for a “moonshot” campaign to cut the death rate from cancer by at least 50% over the next 25 years focuses renewed attention on ensuring access to affordable cancer care for patients living with low incomes and … [Read More...]

UPDATED: Drugmakers Cutting 340B Discounts Reported Record Revenues Last Year

August 24, 2022– Note: This story is updated to include information for additional drug companies that have imposed 340B restrictions since March 2022. The 18 drug companies that have imposed restrictions on safety-net hospital access to 340B drug … [Read More...]

340B Helps Replace Emergency Care with Coordinated Care